Cite
Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components.
MLA
Li, Rongyang, et al. “Prognostic Significance and Survival Benefits of Postoperative Adjuvant Chemotherapy in Patients with Stage IA Lung Adenocarcinoma with Non-Predominant Micropapillary Components.” World Journal of Surgical Oncology, vol. 22, no. 1, Jan. 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s12957-024-03303-x.
APA
Li, R., Qiu, J., Li, Z., Li, H., Tang, Z., Yu, W., Tian, H., & Sun, Z. (2024). Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components. World Journal of Surgical Oncology, 22(1), 1–13. https://doi.org/10.1186/s12957-024-03303-x
Chicago
Li, Rongyang, Jianhao Qiu, Zhenyi Li, Haiming Li, Zhanpeng Tang, Wenhao Yu, Hui Tian, and Zhenguo Sun. 2024. “Prognostic Significance and Survival Benefits of Postoperative Adjuvant Chemotherapy in Patients with Stage IA Lung Adenocarcinoma with Non-Predominant Micropapillary Components.” World Journal of Surgical Oncology 22 (1): 1–13. doi:10.1186/s12957-024-03303-x.